These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2344883)

  • 1. Aggressive polychemotherapy for acute myelofibrosis.
    Hertenstein B; Kurrle E; Frickhofen N; Heil G; Heimpel H
    Eur J Haematol; 1990 Apr; 44(4):213-9. PubMed ID: 2344883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
    Malpas J; Mathé G; Hayat M
    Bull Cancer; 1974; 61(3):411-8. PubMed ID: 4533741
    [No Abstract]   [Full Text] [Related]  

  • 3. Preliminary results of a trial on acute myeloid leukemia comparing the effect of cytosine arabinoside, the combination of cytosine arabinoside and thioguanine and the combination of cytosine arabinoside and daunorubicine.
    Recent Results Cancer Res; 1973; 43():165-8. PubMed ID: 4531077
    [No Abstract]   [Full Text] [Related]  

  • 4. High remission-induction rate in acute myeloid leukaemia.
    Gale RP; Cline MJ
    Lancet; 1977 Mar; 1(8010):497-9. PubMed ID: 65605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A second comparative trial of remission induction (by cytosine arabinoside given every 12 hours, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia.
    Eur J Cancer (1965); 1974 Jul; 10(7):413-8. PubMed ID: 4532961
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug-induced kinetic perturbations of the marrow blasts in acute leukemia. Effects of the daunorubicin, cytosine arabinoside and 6-thioguanine combination.
    Amadori S; Petti MC; Mastrovincenzo C; Testa MG
    Acta Haematol; 1979; 61(5):237-42. PubMed ID: 111451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diminished bone marrow fibrosis on autopsy in a patient with acute myelofibrosis following chemotherapy].
    Okada K; Ohsaka A; Tsuboyama A; Takeda K; Sasaki R; Kano Y; Sakamoto S; Hirota N; Miura Y
    Rinsho Ketsueki; 1986 Sep; 27(9):1661-7. PubMed ID: 3806976
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparative trial of remission induction (by cytosine arabinoside, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia.
    Biomedicine; 1973 May; 18(3):192-8. PubMed ID: 4517790
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of dysmyelopoietic/leukemic syndromes with myelofibrosis and megakaryocytic hyperplasia with large doses of cytosine arabinoside.
    Preisler HD; Raza A; Barcos M
    Med Oncol Tumor Pharmacother; 1985; 2(2):87-91. PubMed ID: 4058079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of thioguanine on a combination of daunorubicine, cytarabine and prednisone in the treatment of acute leukaemia in adults. The Finnish Leukaemia Group.
    Scand J Haematol; 1979 Aug; 23(2):124-8. PubMed ID: 291122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractionated anthracycline therapy in acute myeloblastic leukaemia in adults.
    Donohue SM; Boughton BJ
    Cancer Chemother Pharmacol; 1989; 23(6):401-2. PubMed ID: 2713963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of acute leukemia in adults with cytosine arabinoside and thioguanine].
    Kotlarek-Haus S; Lawińska B; Kuliszkiewicz-Janus M
    Acta Haematol Pol; 1978; 9(4):237-42. PubMed ID: 735711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult acute leukaemia.
    Atkinson K; Wells DG; Clink HM; Kay HE; Powles R; McElwain TJ
    Br J Cancer; 1974 Sep; 30(3):272-8. PubMed ID: 4141625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemia.
    Carey RW; Ribas-Mundo M; Ellison RR; Glidewell O; Lee ST; Cuttner J; Levy RN; Silver R; Blom J; Haurani F; Spurr CL; Harley JB; Kyle R; Moon JH; Eagan RT; Holland JH
    Cancer; 1975 Nov; 36(5):1560-6. PubMed ID: 1059499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow fibre content in acute myeloid leukaemia before and after treatment.
    Islam A; Catovsky D; Goldman JM; Galton DA
    J Clin Pathol; 1984 Nov; 37(11):1259-63. PubMed ID: 6594351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute refractory lymphoblastic leukemia in the adult. Treatment with daunorubicin, cytosine arabinoside, 6-thioguanine, vincristine and prednisone].
    Marín P; Grañena A; Carreras E; Ribera JM; Rozman C
    Sangre (Barc); 1984; 29(6):987-92. PubMed ID: 6598237
    [No Abstract]   [Full Text] [Related]  

  • 17. Two years' experience in the treatment of acute myeloid leukaemia using a three-drug regimen: daunorubicin, cytosine arabinoside and 6-thioguanine.
    McCann SR; Lawlor E; Kinsella IA; Temperley IJ
    Ir Med J; 1982 Nov; 75(11):415-7. PubMed ID: 6959984
    [No Abstract]   [Full Text] [Related]  

  • 18. Daunomycin, cytosin-arabinoside and VP-16 (DAV) for myeloid blast crisis of CML.
    Anger B; Heimpel H
    Blut; 1989 Jun; 58(6):299-301. PubMed ID: 2660927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy using L-asparaginase, daunorubicin, and cytosine arabinoside in adults with acute myelogenous leukaemia.
    Crowther D; Bateman CJ; Vartan CP; Whitehouse JM; Malpas JS; Fairley GH; Scott RB
    Br Med J; 1970 Nov; 4(5734):513-7. PubMed ID: 4921703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged maintained remissions of adult acute non-lymphocytic leukaemia.
    Peterson BA; Bloomfield CD
    Lancet; 1977 Jul; 2(8030):158-60. PubMed ID: 69780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.